NegativeDouble Blind Clinical Trial2020
Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder ('CANSLEEP' trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial
Classification Results
AI Classification
NegativeFine-tuned Classification
N/A